Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Acute myeloid leukemia
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
2 | Adipocytokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Adipocytokine signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
3 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬AGE-RAGE signaling pathway in diabetic complications
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
4 | Alcoholic liver disease 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Alcoholic liver disease
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
5 | Alzheimer disease 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Alzheimer disease
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
6 | Amoebiasis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Amoebiasis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
7 | Apoptosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Apoptosis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
8 | B cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬B cell receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
9 | C-type lectin receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬C-type lectin receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
10 | cAMP signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬cAMP signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
11 | Cellular senescence 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Cellular senescence
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
12 | Chagas disease 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Chagas disease
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
13 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Chemical carcinogenesis - reactive oxygen species
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
14 | Chemical carcinogenesis - receptor activation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Chemical carcinogenesis - receptor activation
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
15 | Chemokine signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Chemokine signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
16 | Chronic myeloid leukemia 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Chronic myeloid leukemia
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
17 | Cocaine addiction 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Cocaine addiction
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
18 | Coronavirus disease - COVID-19 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Coronavirus disease - COVID-19
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
19 | Cytosolic DNA-sensing pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Cytosolic DNA-sensing pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
20 | Diabetic cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Diabetic cardiomyopathy
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
21 | Epithelial cell signaling in Helicobacter pylori infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Epithelial cell signaling in Helicobacter pylori infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
22 | Epstein-Barr virus infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Epstein-Barr virus infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
23 | Fluid shear stress and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Fluid shear stress and atherosclerosis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
24 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Hepatitis B
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
25 | Hepatitis C 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Hepatitis C
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
26 | Herpes simplex virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Herpes simplex virus 1 infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
27 | HIF-1 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬HIF-1 signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
28 | Human cytomegalovirus infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Human cytomegalovirus infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
29 | Human immunodeficiency virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Human immunodeficiency virus 1 infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
30 | Human papillomavirus infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Human papillomavirus infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
31 | Human T-cell leukemia virus 1 infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Human T-cell leukemia virus 1 infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
32 | IL-17 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬IL-17 signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
33 | Inflammatory bowel disease 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Inflammatory bowel disease
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
34 | Influenza A 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Influenza A
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
35 | Insulin resistance 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Insulin resistance
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
36 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Kaposi sarcoma-associated herpesvirus infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
37 | Legionellosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Legionellosis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
38 | Leishmaniasis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Leishmaniasis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
39 | Lipid and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Lipid and atherosclerosis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
40 | Longevity regulating pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Longevity regulating pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
41 | MAPK signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬MAPK signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
42 | Measles 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Measles
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
43 | Mitophagy - animal 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Mitophagy - animal
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
44 | Neurotrophin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Neurotrophin signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
45 | Neutrophil extracellular trap formation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Neutrophil extracellular trap formation
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
46 | NF-kappa B signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬NF-kappa B signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
47 | NOD-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬NOD-like receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
48 | Non-alcoholic fatty liver disease 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Non-alcoholic fatty liver disease
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
49 | Osteoclast differentiation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Osteoclast differentiation
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
50 | Pancreatic cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Pancreatic cancer
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
51 | Pathogenic Escherichia coli infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Pathogenic Escherichia coli infection
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
52 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Pathways in cancer
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
53 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Pathways of neurodegeneration - multiple diseases
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
54 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
55 | Pertussis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Pertussis
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
56 | PI3K-Akt signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬PI3K-Akt signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
57 | Prolactin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Prolactin signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
58 | Prostate cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Prostate cancer
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
59 | Ras signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬Acute myeloid leukemia
|
Edasalonexent Edasalonexent 💬Ras signaling pathway
| Edasalonexent | 113 [1] 113 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||
60 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬60. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
61 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬60. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
62 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Macitentan Macitentan 💬Relaxin signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬62. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
63 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Afatinib Afatinib 💬Relaxin signaling pathway
| Afatinib | 285 [1] 285 💬63. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
64 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Afatinib dimaleate Afatinib dimaleate 💬Relaxin signaling pathway
| Afatinib | 285 [1] 285 💬63. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
65 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Cetuximab Cetuximab 💬Relaxin signaling pathway
| Cetuximab | 034 [5] 34, 51, 86, 89, 331 💬65. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
66 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬66. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
67 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib Erlotinib 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬66. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
68 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Gefitinib Gefitinib 💬Relaxin signaling pathway
| Gefitinib | 075 [1] 75 💬68. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
69 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Icotinib Icotinib 💬Relaxin signaling pathway
| Icotinib | 034 [1] 34 💬69. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
70 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Lapatinib ditosylate Lapatinib ditosylate 💬Relaxin signaling pathway
| Lapatinib | 034 [3] 34, 74, 75 💬70. Relaxin signaling pathway |
||||||||||||||||||||||||||||||||
71 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Lapatinib Lapatinib 💬Relaxin signaling pathway
| Lapatinib | 034 [3] 34, 74, 75 💬70. Relaxin signaling pathway |
||||||||||||||||||||||||||||||||
72 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Neratinib Neratinib 💬Relaxin signaling pathway
| Neratinib | 034 [1] 34 💬72. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
73 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Neratinib maleate Neratinib maleate 💬Relaxin signaling pathway
| Neratinib | 034 [1] 34 💬72. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
74 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Tesevatinib Tesevatinib 💬Relaxin signaling pathway
| Tesevatinib | 067 [1] 67 💬74. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
75 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Binimetinib Binimetinib 💬Relaxin signaling pathway
| Binimetinib | 034 [1] 34 💬75. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
76 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Cobimetinib Cobimetinib 💬Relaxin signaling pathway
| Cobimetinib | 280 [1] 280 💬76. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
77 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Cobimetinib fumarate Cobimetinib fumarate 💬Relaxin signaling pathway
| Cobimetinib | 280 [1] 280 💬76. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
78 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Mirdametinib Mirdametinib 💬Relaxin signaling pathway
| Mirdametinib | 034 [4] 34, 278, 279, 280 💬78. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
79 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Selumetinib Selumetinib 💬Relaxin signaling pathway
| Selumetinib | 034 [1] 34 💬79. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
80 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Selumetinib sulfate Selumetinib sulfate 💬Relaxin signaling pathway
| Selumetinib | 034 [1] 34 💬79. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
81 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Trametinib Trametinib 💬Relaxin signaling pathway
| Trametinib | 002 [6] 2 , 34, 58, 195, 279, 280 💬81. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
82 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MAP2K1 [2] MAP2K1, MAP2K2 💬
|
Trametinib dimethyl sulfoxide Trametinib dimethyl sulfoxide 💬Relaxin signaling pathway
| Trametinib | 002 [6] 2 , 34, 58, 195, 279, 280 💬81. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
83 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MMP13 [1] MMP13 💬Relaxin signaling pathway
|
Apratastat Apratastat 💬Relaxin signaling pathway
| Apratastat | 046 [1] 46 💬83. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
84 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
MMP9 [1] MMP9 💬Relaxin signaling pathway
|
Andecaliximab Andecaliximab 💬Relaxin signaling pathway
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬84. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
85 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
NFKB1 [1] NFKB1 💬Relaxin signaling pathway
|
Iguratimod Iguratimod 💬Relaxin signaling pathway
| Iguratimod | 046 [6] 46, 49, 51, 53, 271, 300 💬85. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
86 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
NOS1 [3] NOS1, NOS2, NOS3 💬
|
Tilarginine acetate Tilarginine acetate 💬Relaxin signaling pathway
| Tilarginine | 067 [1] 67 💬86. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
87 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
P38 [4] P38, P38, P38, P38 💬
|
Losmapimod Losmapimod 💬Relaxin signaling pathway
| Losmapimod | 113 [2] 113, 222 💬87. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
88 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
P38 [4] P38, P38, P38, P38 💬
|
Neflamapimod Neflamapimod 💬Relaxin signaling pathway
| Neflamapimod | 008 [1] 8 💬88. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
89 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [1] PIK3CA_B_D 💬Relaxin signaling pathway
|
Alpelisib Alpelisib 💬Relaxin signaling pathway
| Alpelisib | 138 [4] 138, 278, 279, 280 💬89. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
90 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [1] PIK3CA_B_D 💬Relaxin signaling pathway
|
Leniolisib phosphate Leniolisib phosphate 💬Relaxin signaling pathway
| Leniolisib | 053 [2] 53, 65 💬90. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
91 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [1] PIK3CA_B_D 💬Relaxin signaling pathway
|
Parsaclisib Parsaclisib 💬Relaxin signaling pathway
| Parsaclisib | 035 [3] 35, 53, 61 💬
|
||||||||||||||||||||||||||||||||
92 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [2] PIK3CA_B_D, PIK3CA_B_D 💬Relaxin signaling pathway
|
Copanlisib Copanlisib 💬Relaxin signaling pathway
| Copanlisib | 121 [1] 121 💬92. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
93 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA_B_D [3] PIK3CA_B_D, PIK3CA_B_D, PIK3CA_B_D 💬Relaxin signaling pathway
|
Leniolisib Leniolisib 💬Relaxin signaling pathway
| Leniolisib | 053 [2] 53, 65 💬93. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
94 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
RAF1 [1] RAF1 💬Relaxin signaling pathway
|
Sorafenib tosylate Sorafenib tosylate 💬Relaxin signaling pathway
| Sorafenib | 034 [2] 34, 86 💬
|
||||||||||||||||||||||||||||||||
95 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
RAF1 [1] RAF1 💬Relaxin signaling pathway
|
Sorafenib Sorafenib 💬Relaxin signaling pathway
| Sorafenib | 034 [2] 34, 86 💬
|
||||||||||||||||||||||||||||||||
96 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
RELA [1] RELA 💬Relaxin signaling pathway
|
Edasalonexent Edasalonexent 💬Relaxin signaling pathway
| Edasalonexent | 113 [1] 113 💬96. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
97 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
SRC [1] SRC 💬Relaxin signaling pathway
|
Bosutinib Bosutinib 💬Relaxin signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||
98 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
SRC [1] SRC 💬Relaxin signaling pathway
|
Bosutinib hydrate Bosutinib hydrate 💬Relaxin signaling pathway
| Bosutinib | 002 [2] 2 , 67 💬
|
||||||||||||||||||||||||||||||||
99 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
SRC [1] SRC 💬Relaxin signaling pathway
|
Dasatinib Dasatinib 💬Relaxin signaling pathway
| Dasatinib | 051 [2] 51, 85 💬99. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
100 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
SRC [1] SRC 💬Relaxin signaling pathway
|
Dasatinib Dasatinib 💬Relaxin signaling pathway
| Dasatinib | 051 [2] 51, 85 💬99. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
101 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
SRC [1] SRC 💬Relaxin signaling pathway
|
Saracatinib Saracatinib 💬Relaxin signaling pathway
| Saracatinib | 006 [3] 6 , 89, 272 💬
|
||||||||||||||||||||||||||||||||
102 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
TGFB1 [1] TGFB1 💬Relaxin signaling pathway
|
Fresolimumab Fresolimumab 💬Relaxin signaling pathway
| Fresolimumab | 051 [4] 51, 85, 222, 274 💬102. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
103 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
VEGFA [1] VEGFA 💬Relaxin signaling pathway
|
Bevacizumab Bevacizumab 💬Relaxin signaling pathway
| Bevacizumab | 013 [8] 13, 34, 85, 87, 89, 227, 280, 331 💬103. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
104 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
VEGFA [1] VEGFA 💬Relaxin signaling pathway
|
Ranibizumab Ranibizumab 💬Relaxin signaling pathway
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬104. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||
105 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
VEGFA [2] VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬Relaxin signaling pathway
| Aflibercept | 090 [2] 90, 166 💬
|
||||||||||||||||||||||||||||||||
106 | RIG-I-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬RIG-I-like receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
107 | Salmonella infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Salmonella infection
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
108 | Shigellosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Shigellosis
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
109 | Small cell lung cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Small cell lung cancer
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
110 | Sphingolipid signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Sphingolipid signaling pathway
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
111 | T cell receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬T cell receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
112 | Th1 and Th2 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Th1 and Th2 cell differentiation
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
113 | Th17 cell differentiation 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Th17 cell differentiation
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
114 | TNF signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬TNF signaling pathway
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
115 | Toll-like receptor signaling pathway 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Toll-like receptor signaling pathway
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
116 | Toxoplasmosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Toxoplasmosis
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
117 | Transcriptional misregulation in cancer 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Transcriptional misregulation in cancer
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
118 | Tuberculosis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Tuberculosis
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
119 | Viral carcinogenesis 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Viral carcinogenesis
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||
120 | Yersinia infection 💬 1 gene, 1 drug (DrugBank) and 1 disease |
RELA [1] RELA 💬RIG-I-like receptor signaling pathway
|
Edasalonexent Edasalonexent 💬Yersinia infection
| Edasalonexent | 113 [1] 113 💬106. RIG-I-like receptor signaling pathway
|
Acute myeloid leukemia
1 gene, 1 drug (DrugBank) and 1 disease
Adipocytokine signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
AGE-RAGE signaling pathway in diabetic complications
1 gene, 1 drug (DrugBank) and 1 disease
Alcoholic liver disease
1 gene, 1 drug (DrugBank) and 1 disease
Alzheimer disease
1 gene, 1 drug (DrugBank) and 1 disease
Amoebiasis
1 gene, 1 drug (DrugBank) and 1 disease
Apoptosis
1 gene, 1 drug (DrugBank) and 1 disease
B cell receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
C-type lectin receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
cAMP signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Cellular senescence
1 gene, 1 drug (DrugBank) and 1 disease
Chagas disease
1 gene, 1 drug (DrugBank) and 1 disease
Chemical carcinogenesis - reactive oxygen species
1 gene, 1 drug (DrugBank) and 1 disease
Chemical carcinogenesis - receptor activation
1 gene, 1 drug (DrugBank) and 1 disease
Chemokine signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Chronic myeloid leukemia
1 gene, 1 drug (DrugBank) and 1 disease
Cocaine addiction
1 gene, 1 drug (DrugBank) and 1 disease
Coronavirus disease - COVID-19
1 gene, 1 drug (DrugBank) and 1 disease
Cytosolic DNA-sensing pathway
1 gene, 1 drug (DrugBank) and 1 disease
Diabetic cardiomyopathy
1 gene, 1 drug (DrugBank) and 1 disease
Epithelial cell signaling in Helicobacter pylori infection
1 gene, 1 drug (DrugBank) and 1 disease
Epstein-Barr virus infection
1 gene, 1 drug (DrugBank) and 1 disease
Fluid shear stress and atherosclerosis
1 gene, 1 drug (DrugBank) and 1 disease
Hepatitis B
1 gene, 1 drug (DrugBank) and 1 disease
Hepatitis C
1 gene, 1 drug (DrugBank) and 1 disease
Herpes simplex virus 1 infection
1 gene, 1 drug (DrugBank) and 1 disease
HIF-1 signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Human cytomegalovirus infection
1 gene, 1 drug (DrugBank) and 1 disease
Human immunodeficiency virus 1 infection
1 gene, 1 drug (DrugBank) and 1 disease
Human papillomavirus infection
1 gene, 1 drug (DrugBank) and 1 disease
Human T-cell leukemia virus 1 infection
1 gene, 1 drug (DrugBank) and 1 disease
IL-17 signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Inflammatory bowel disease
1 gene, 1 drug (DrugBank) and 1 disease
Influenza A
1 gene, 1 drug (DrugBank) and 1 disease
Insulin resistance
1 gene, 1 drug (DrugBank) and 1 disease
Kaposi sarcoma-associated herpesvirus infection
1 gene, 1 drug (DrugBank) and 1 disease
Legionellosis
1 gene, 1 drug (DrugBank) and 1 disease
Leishmaniasis
1 gene, 1 drug (DrugBank) and 1 disease
Lipid and atherosclerosis
1 gene, 1 drug (DrugBank) and 1 disease
Longevity regulating pathway
1 gene, 1 drug (DrugBank) and 1 disease
MAPK signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Measles
1 gene, 1 drug (DrugBank) and 1 disease
Mitophagy - animal
1 gene, 1 drug (DrugBank) and 1 disease
Neurotrophin signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Neutrophil extracellular trap formation
1 gene, 1 drug (DrugBank) and 1 disease
NF-kappa B signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
NOD-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Non-alcoholic fatty liver disease
1 gene, 1 drug (DrugBank) and 1 disease
Osteoclast differentiation
1 gene, 1 drug (DrugBank) and 1 disease
Pancreatic cancer
1 gene, 1 drug (DrugBank) and 1 disease
Pathogenic Escherichia coli infection
1 gene, 1 drug (DrugBank) and 1 disease
Pathways in cancer
1 gene, 1 drug (DrugBank) and 1 disease
Pathways of neurodegeneration - multiple diseases
1 gene, 1 drug (DrugBank) and 1 disease
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 1 drug (DrugBank) and 1 disease
Pertussis
1 gene, 1 drug (DrugBank) and 1 disease
PI3K-Akt signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Prolactin signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Prostate cancer
1 gene, 1 drug (DrugBank) and 1 disease
Ras signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
RIG-I-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Salmonella infection
1 gene, 1 drug (DrugBank) and 1 disease
Shigellosis
1 gene, 1 drug (DrugBank) and 1 disease
Small cell lung cancer
1 gene, 1 drug (DrugBank) and 1 disease
Sphingolipid signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
T cell receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Th1 and Th2 cell differentiation
1 gene, 1 drug (DrugBank) and 1 disease
Th17 cell differentiation
1 gene, 1 drug (DrugBank) and 1 disease
TNF signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Toll-like receptor signaling pathway
1 gene, 1 drug (DrugBank) and 1 disease
Toxoplasmosis
1 gene, 1 drug (DrugBank) and 1 disease
Transcriptional misregulation in cancer
1 gene, 1 drug (DrugBank) and 1 disease
Tuberculosis
1 gene, 1 drug (DrugBank) and 1 disease
Viral carcinogenesis
1 gene, 1 drug (DrugBank) and 1 disease
Yersinia infection
1 gene, 1 drug (DrugBank) and 1 disease